Plain-English translation of NCT06163534 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is collecting blood and tumor tissue samples from people with advanced head and neck cancer who are beginning immunotherapy treatment. Researchers want to understand the genetic and molecular patterns in each person's cancer to predict who will respond well to treatment and to improve how doctors choose the best therapy for each patient.
Some patients with advanced head and neck cancer respond very well to immunotherapy, while others do not. By studying the unique characteristics of each person's cancer through blood and tissue samples collected over time, researchers hope to identify patterns that predict who will benefit most from this treatment, allowing doctors to personalize care and avoid ineffective therapies.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive your regular cancer treatment as planned. During your standard doctor visits, the research team will collect extra blood samples and obtain a sample of your tumor tissue to analyze. These samples will be studied over time to track changes in your cancer's characteristics as you receive treatment. There is no additional medication or special procedures — the study simply involves donating samples alongside your regular care.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States